Substrate
financeSourced

Shopify Discloses Regulation FD Information in SEC Filing

Shopify Inc. filed a Form 8-K with the SEC on June 2, 2026, reporting items under Regulation FD disclosure and exhibits. The filing triggers standard requirements for public companies to furnish material information to the SEC and maintain updated disclosures for investors and regulators.

SEC EDGAR — SHOPIFY INC. (SHOP)
1 source·Jun 1, 8:00 PM·1m read
Shopify Discloses Regulation FD Information in SEC Filing680news.com
Audio version
Tap play to generate a narrated version.

Shopify Inc. filed a Form 8-K with the Securities and Exchange Commission on June 2, 2026, citing Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits.

The filing covers the Canadian e-commerce company, which reported $8.9 billion in revenue for fiscal year 2025 and serves more than 2 million merchants worldwide. Shopify's market capitalization exceeded $150 billion as of the most recent trading session prior to the filing.

The 8-K establishes a new public record of the disclosed information as of June 2, 2026. Prior to the filing, the information had not been furnished in a Form 8-K. The disclosure takes effect immediately upon filing and becomes part of the company's permanent SEC reporting history.

The filing requires Shopify to ensure the disclosed material aligns with its ongoing Exchange Act obligations. It starts the clock for any related follow-on disclosures if the information triggers additional Form 8-K items or amendments. Market participants and regulators now have formal access to the furnished exhibits for due diligence, compliance reviews, or potential future enforcement reference.

Separate filings may be required if the disclosed information relates to material contracts, financial restatements, or executive compensation that demand independent reporting.

This marks the latest Regulation FD disclosure by Shopify in 2026. The company has maintained active SEC reporting since its 2015 initial public offering, with prior 8-K filings addressing quarterly results, executive changes, and material agreements under the same CIK 0001594805.

Coverage spread

Substrate’s article above is written from the primary record. Below: how mainstream outlets reported the same event.

No mainstream coverage of this story has surfaced yet.

Transparency

Confidence90%

Reported by a single outlet. This score reflects source tier and factual specificity — corroboration is limited with one source.

Related Stories

U.S. Strikes Botswana-Flagged Tanker in International Waters; Iran Blockade in Effectthehindu.com
finance41 min ago

U.S. Strikes Botswana-Flagged Tanker in International Waters; Iran Blockade in Effect

A U.S. aircraft fired an AGM-114 Hellfire missile into the engine room of the M/T Lexie on Tuesday, disabling the unladen vessel as it headed toward Kharg Island. The strike followed repeated ignored warnings over 24 hours.

FI
FI
OS
BBC News
4 sources
Fed Chairman Names Two Outside Advisers During Transitionprnewswire.com
finance41 min ago

Fed Chairman Names Two Outside Advisers During Transition

Federal Reserve Chairman Kevin Warsh appointed two interim advisers shortly after taking the post. One previously contributed to a conservative plan calling for major changes at the central bank.

FI
Wall Street Journal
2 sources
Forte Biosciences Accepts Resignation of Director David Veitchinsidermonkey.com
finance2 hrs agoSourced

Forte Biosciences Accepts Resignation of Director David Veitch

Forte Biosciences disclosed the resignation of independent director David Veitch from its board effective June 1 2026. The departure reduces the company's board size and triggers standard SEC and Nasdaq disclosure obligations for director changes at the clinical-stage biopharmace…

SEC EDGAR — Forte Biosciences, Inc. (FBRX)
1 source